QDOLO

Peak

tramadol hydrochloride

NDAORALSOLUTION
Approved
Sep 2020
Lifecycle
Peak
Competitive Pressure
0/100
Clinical Trials
15

Clinical Trials (5)

NCT03803371Phase 4Completed

Bioequivalence Study of Tramadol Hydrochloride /Paracetamol Tablets Versus Ultracet Tablets

Started Mar 2019
60 enrolled
Healthy
NCT02307864Phase 1Completed

Study to Evaluate the Effects of Tramadol Hydrochloride on Cardiac Repolarization in Healthy Participants

Started Dec 2014
68 enrolled
Healthy
NCT01947920Phase 1Completed

A Dose Ranging Escalation Study of Tramadol Hydrochloride in Healthy Volunteers

Started Aug 2013
30 enrolled
Healthy
NCT01819805N/ACompleted

A Study to Assess the Improvement of Pain and Health-Related Quality of Life in Patients With Chronic Non-Malignant Pain Taking Tramadol Hydrochloride and Acetaminophen

Started Sep 2011
1,065 enrolled
Chronic Pain
NCT01814878Phase 3Completed

A Study Comparing the Effectiveness and Safety of Extended Release (ER) Tramadol Hydrochloride (HCl)/Acetaminophen With Immediate Release (IR) Tramadol HCl/Acetaminophen in Participants With Moderate to Severe Postoperative Pain

Started Nov 2009
320 enrolled
Pain, Postoperative

Loss of Exclusivity

LOE Date
Sep 1, 2040
176 months away
Patent Expiry
Sep 1, 2040

Patent Records (2)

Patent #ExpiryTypeUse Code
11103452
Sep 1, 2040
Product
U-3197
11752103
Sep 1, 2040
Product
U-3197